AbbVie Stocks Decline 2.3% With RBC Target Increase Backing Its Immunology Transition
Published . Updated .
RBC raises its target to $330 while retaining Outperform after the latest quarterly results.
Directly affected
- ABBV AbbVie+11.4% 30d
Named in this report.
Indirectly affected
- DIA SPDR Dow Jones Industrial Average ETF-1.7% 30d
SPDR Dow Jones Industrial Average ETF: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story.
- QQQ Invesco QQQ-2.6% 30d
Invesco QQQ: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story.
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that AbbVie belongs to, so it often moves with news about it.
- LLY Eli Lilly and+21.6% 30d
Eli Lilly and is a peer of AbbVie in pharmaceutical preparations; rivals often move on the same news.
- JNJ Johnson & Johnson+1.5% 30d
Johnson & Johnson is a peer of AbbVie in pharmaceutical preparations; rivals often move on the same news.
- MRK Merck+3.2% 18d
Merck is a peer of AbbVie in pharmaceutical preparations; rivals often move on the same news.
- ABT Abbott Laboratories+3.1% 30d
Abbott Laboratories is a peer of AbbVie in pharmaceutical preparations; rivals often move on the same news.
- PFE Pfizer+8.9% 30d
Pfizer is a peer of AbbVie in pharmaceutical preparations; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| ABBV | -2.71% | -2.90% | base | -2.14% | after close | after close | after close |
| DIA | +1.17% | +1.48% | base | +1.03% | after close | after close | after close |
| QQQ | +3.12% | +5.08% | base | +0.17% | after close | after close | after close |
| XLVNo price data for this ticker | — | — | — | — | — | — | — |
| LLYNo price data for this ticker | — | — | — | — | — | — | — |
| JNJNo price data for this ticker | — | — | — | — | — | — | — |
| MRKNo price data for this ticker | — | — | — | — | — | — | — |
| ABTNo price data for this ticker | — | — | — | — | — | — | — |
| PFENo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
AbbVie Stocks Decline 2.3% With RBC Target Increase Backing Its Immunology Transition Yahoo Finance
Source: Yahoo Finance
Price since this story was published: Spdr Dow Jones Industrial Average Etf Trust (DIA)
| Company | When | Move | Status |
|---|---|---|---|
| ABBV | that day | -2.14% | still updating |
| ABBV | three days earlier | -2.90% | final price |
| ABBV | five days earlier | -2.71% | final price |
| Spdr Dow Jones Industrial Average Etf Trust (DIA) | that day | +1.03% | still updating |
| Spdr Dow Jones Industrial Average Etf Trust (DIA) | three days earlier | +1.48% | final price |
| Spdr Dow Jones Industrial Average Etf Trust (DIA) | five days earlier | +1.17% | final price |
| Invesco Qqq Trust, Series 1 (QQQ) | that day | +0.17% | still updating |
| Invesco Qqq Trust, Series 1 (QQQ) | three days earlier | +5.08% | final price |
| Invesco Qqq Trust, Series 1 (QQQ) | five days earlier | +3.12% | final price |
Congressional trades in the stocks in this story
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 49 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 38 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 55 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 39 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 75 days before publication. Filed 9 Sep 2026. View the filing.
- Rep. Pete Sessions sold Abbott Laboratories (ABT) (held by a spouse), worth $50,001 - $100,000 on 2 Oct 2026. That is 31 days before publication. Filed 27 Oct 2026. View the filing.
- Rep. Gilbert Cisneros bought Abbott Laboratories (ABT), worth $1,001 - $15,000 on 18 Sep 2026. That is 45 days before publication. Filed 12 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Abbott Laboratories (ABT) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Spdr Dow Jones Industrial Average Etf Trust (DIA)
Companies tied to this story
- DIA Spdr Dow Jones Industrial Average Etf Trust
In “AbbVie Stocks Decline 2.3% With RBC Target Increase Backing Its Immunology Transition,” Spdr Dow Jones Industrial Average Etf Trust (DIA) is linked, with no stored direction, medium confidence. Reason on file: SPDR Dow Jones Industrial Average ETF: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story
- QQQ Invesco Qqq Trust, Series 1
Invesco Qqq Trust, Series 1 (QQQ) is linked, with no stored direction, medium confidence in the 2 Nov 2026 story “AbbVie Stocks Decline 2.3% With RBC Target Increase Backing Its Immunology Transition.” Reason on file: Invesco QQQ: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story
- IWM Ishares Tr
Ishares Tr (IWM) is linked, with no stored direction, medium confidence in the 2 Nov 2026 story “AbbVie Stocks Decline 2.3% With RBC Target Increase Backing Its Immunology Transition.” Reason on file: iShares Russell 2000 ETF: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story
- RSP Invesco Exchange Traded Fd T
For “AbbVie Stocks Decline 2.3% With RBC Target Increase Backing Its Immunology Transition,” Invesco Exchange Traded Fd T (RSP) is linked, with no stored direction, medium confidence. Reason on file: Invesco S&P 500 Equal Weight ETF: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story
- VTI Vanguard Index Fds
Vanguard Index Fds (VTI) is linked, with no stored direction, medium confidence in the 2 Nov 2026 story “AbbVie Stocks Decline 2.3% With RBC Target Increase Backing Its Immunology Transition.” Reason on file: Vanguard Total Stock Market ETF: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story
Spdr Dow Jones Industrial Average Etf Trust (DIA)
The 2 Nov 2026 story “AbbVie Stocks Decline 2.3% With RBC Target Increase Backing Its Immunology Transition” names Spdr Dow Jones Industrial Average Etf Trust (DIA) because of this story.
For Spdr Dow Jones Industrial Average Etf Trust (DIA), the reason on file says SPDR Dow Jones Industrial Average ETF: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story
Invesco Qqq Trust, Series 1 (QQQ) is here too. Its reason reads: Invesco QQQ: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story
The price range for Spdr Dow Jones Industrial Average Etf Trust (DIA), and the dates in the story
DIA traded between 504.92 and 522.62 across 18 sessions. The latest close on file is 515.65. IWM traded between 269.88 and 285.25 across 20 sessions. The latest close on file is 279.37. QQQ traded between 683.47 and 762.84 across 20 sessions. The latest close on file is 690.51.
A simple score for Spdr Dow Jones Industrial Average Etf Trust (DIA)
40 out of 100Price not final
“AbbVie Stocks Decline 2.3% With RBC Target Increase Backing Its Immunology Transition” scores 40 out of 100. The score uses 1 sources, and 5 linked companies. The price is not final yet.